Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
CB Financial Services
CBFV
$189M
| $1.2M | ﹤0.01% |
55,799
-2,670
| -5% | -$58.1K |
|
2427
Hippo Holdings
HIPO
$872M
| $1.2M | ﹤0.01% |
87,904
+12,800
| +17% | +$192K |
|
2428
OneSpan
OSPN
$602M
| $1.19M | ﹤0.01% |
106,300
-87,060
| -45% | -$1M |
|
2429
CS Disco
LAW
$286M
| $1.19M | ﹤0.01% |
187,998
+124,498
| +196% | +$1.06M |
|
|
CTHR
2430
DELISTED
Charles & Colvard Ltd
CTHR
| $1.18M | ﹤0.01% |
143,937
-10,720
| -7% | -$101K |
|
2431
Espey Mfg & Electronics Corp
ESP
$192M
| $1.18M | ﹤0.01% |
83,012
-6,800
| -8% | -$91.9K |
|
2432
Funko
FNKO
$344M
| $1.18M | ﹤0.01% |
108,068
-176,400
| -62% | -$2.48M |
|
2433
Avantis Emerging Markets Equity ETF
AVEM
$26.9B
| $1.18M | ﹤0.01% |
23,308
-4,292
| -16% | -$210K |
|
2434
Douglas Dynamics
PLOW
$976M
| $1.18M | ﹤0.01% |
32,500
+8,900
| +38% | +$314K |
|
2435
Taysha Gene Therapies
TSHA
$1.9B
| $1.18M | ﹤0.01% |
519,800
+101,300
| +24% | +$205K |
|
2436
TG Therapeutics
TGTX
$7.46B
| $1.17M | ﹤0.01% |
99,100
-80,100
| -45% | -$581K |
|
|
TERN
2437
DELISTED
Terns Pharmaceuticals
TERN
| $1.17M | ﹤0.01% |
114,900
-37,300
| -25% | -$248K |
|
2438
Leonardo DRS
DRS
$12.2B
| $1.17M | ﹤0.01% |
+91,200
| New | +$1.06M |
|
2439
Aware
AWRE
$26.4M
| $1.17M | ﹤0.01% |
681,273
-55,300
| -8% | -$97.8K |
|
2440
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$723M
| $1.16M | ﹤0.01% |
+33,502
| New | +$1.12M |
|
2441
TETRA Technologies
TTI
$1.27B
| $1.16M | ﹤0.01% |
335,676
-112,488
| -25% | -$438K |
|
2442
Yext
YEXT
$594M
| $1.16M | ﹤0.01% |
177,700
-283,300
| -61% | -$1.54M |
|
|
AGFS
2443
DELISTED
AgroFresh Solutions Inc
AGFS
| $1.16M | ﹤0.01% |
391,711
-24,400
| -6% | -$61.2K |
|
2444
Crinetics Pharmaceuticals
CRNX
$8.99B
| $1.16M | ﹤0.01% |
+63,100
| New | +$1.11M |
|
2445
Barnwell Industries
BRN
$13.9M
| $1.15M | ﹤0.01% |
389,722
-42,413
| -10% | -$129K |
|
2446
iShares Expanded Tech-Software Sector ETF
IGV
$14.9B
| $1.15M | ﹤0.01% |
22,500
+14,000
| +165% | +$726K |
|
2447
Northern Technologies International Corp
NTIC
$75.9M
| $1.15M | ﹤0.01% |
86,377
-8,500
| -9% | -$111K |
|
|
CIR
2448
DELISTED
CIRCOR International, Inc
CIR
| $1.15M | ﹤0.01% |
48,005
+36,905
| +332% | +$826K |
|
2449
Burford Capital
BUR
$960M
| $1.15M | ﹤0.01% |
140,800
+12,000
| +9% | +$99.3K |
|
2450
Kodak
KODK
$979M
| $1.14M | ﹤0.01% |
375,000
-26,300
| -7% | -$116K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 522 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 522 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.